Sartorius Stedim Biotech S.A. Stock OTC Markets
Stocks
SRTOY
US80386Y1010
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
OTC Markets
15:59:59 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 21.59 USD | +0.33% |
|
-1.77% | -9.17% |
| 09-08 | Sartorius Stedim Biotech : Barclays remains its Buy rating | ZD |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| Market Cap | 18.18B 21.11B 17.22B 15.61B 29.28B 2,016B 29.43B 205B 78.64B 1,026B 79.26B 77.53B 3,242B | P/E 2026 * |
47.7x | P/E 2027 * | 37x |
|---|---|---|---|---|---|
| Enterprise Value | 20.19B 23.44B 19.12B 17.33B 32.51B 2,239B 32.68B 227B 87.32B 1,139B 88.02B 86.09B 3,599B | EV / Sales 2026 * |
6.46x | EV / Sales 2027 * | 5.75x |
| Free-Float |
28.47% | Yield 2026 * |
0.45% | Yield 2027 * | 0.54% |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| SRTOY | Delayed | |
Deutsche Boerse AG
| 56S0 | Delayed | |
|
Börse Stuttgart
| 56S0 | Delayed |
Last Transcript : Sartorius Stedim Biotech S.A.
| 1 day | +0.33% | ||
| 1 week | -1.77% | ||
| Current month | -5.56% | ||
| 1 month | +4.45% | ||
| 3 months | +7.09% | ||
| 6 months | +16.70% | ||
| Current year | -9.17% |
| 1 week | 21.52 |  | 22.48 |
| 1 month | 20.32 | | 23.43 |
| Current year | 17.25 | | 26.54 |
| 1 year | 17.25 | | 26.54 |
| 3 years | 15.75 | | 30.62 |
| 5 years | 15.75 | | 43.52 |
| 10 years | 15.75 | | 43.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.33% | -1.77% | - | - | 21.11B | |
| -1.36% | -5.89% | -23.76% | -0.44% | 176B | |
| -0.72% | -3.41% | -3.26% | +12.32% | 116B | |
| +0.19% | -2.83% | +6.30% | +80.17% | 61.36B | |
| -1.92% | -6.01% | +7.05% | +38.44% | 49.42B | |
| +0.81% | -3.73% | -4.81% | -32.56% | 48.44B | |
| -1.75% | -5.54% | +8.93% | -20.82% | 31.33B | |
| +0.43% | -11.10% | - | - | 28.54B | |
| +0.58% | +1.84% | +36.58% | -12.08% | 24.37B | |
| +0.49% | -7.65% | -13.30% | +3.79% | 21.57B | |
| Average | -0.29% | -5.08% | +1.72% | +8.60% | 61.98B | |
| Weighted average by Cap. | -0.65% | -4.90% | -6.02% | +10.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.63B 2.96B 2.68B 5.03B 347B 5.06B 35.16B 13.52B 176B 13.63B 13.33B 557B | 3.47B 4.03B 3.28B 2.98B 5.58B 385B 5.61B 39.01B 15B 196B 15.12B 14.79B 618B |
| Net income | 381M 443M 361M 327M 614M 42.29B 617M 4.29B 1.65B 21.51B 1.66B 1.63B 67.98B | 483M 561M 457M 415M 778M 53.57B 782M 5.43B 2.09B 27.25B 2.11B 2.06B 86.12B |
| Net Debt | 2.01B 2.33B 1.9B 1.72B 3.23B 223B 3.25B 22.58B 8.68B 113B 8.75B 8.56B 358B | 1.76B 2.04B 1.66B 1.51B 2.83B 195B 2.84B 19.74B 7.59B 99.03B 7.65B 7.48B 313B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$21.59 | +0.33% | 28,378 |
| 26-09-10 | US$21.52 | -4.27% | 29,630 |
| 26-09-09 | US$22.48 | +2.27% | 45,252 |
| 26-09-08 | US$21.98 | 0.00% | 30,330 |
| 26-09-04 | US$21.98 | -4.48% | 22,209 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- SRTOY Stock
Select your edition
All financial news and data tailored to specific country editions
